TTY Biopharm Co Ltd (4105) — Financial Flexibility Index
TTY Biopharm Co Ltd (4105) has a Financial Flexibility Index of 0.18x as of March 2026. Free cash flow of NT$782.44 Million (operating CF NT$654.16 Million minus capex NT$128.28 Million) represents 0% of total liabilities (NT$4.28 Billion). Check TTY Biopharm Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TTY Biopharm Co Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for TTY Biopharm Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see TTY Biopharm Co Ltd (4105) cash conversion ratio.
Annual Financial Flexibility Index for TTY Biopharm Co Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for TTY Biopharm Co Ltd. Explore TTY Biopharm Co Ltd (4105) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | NT$1.91 Billion | NT$1.76 Billion | NT$3.30 Billion | ▲ +31.1% |
| 2024 | 0.44x | NT$1.48 Billion | NT$1.35 Billion | NT$3.35 Billion | ▲ +25.8% |
| 2023 | 0.35x | NT$1.18 Billion | NT$1.09 Billion | NT$3.37 Billion | ▼ -13.6% |
| 2022 | 0.41x | NT$1.37 Billion | NT$1.24 Billion | NT$3.37 Billion | ▲ +8.0% |
| 2021 | 0.38x | NT$1.33 Billion | NT$1.26 Billion | NT$3.53 Billion | ▲ +74.7% |
| 2020 | 0.22x | NT$708.21 Million | NT$526.35 Million | NT$3.28 Billion | ▼ -43.0% |
| 2019 | 0.38x | NT$1.28 Billion | NT$1.21 Billion | NT$3.38 Billion | ▼ -12.3% |
| 2018 | 0.43x | NT$1.15 Billion | NT$1.07 Billion | NT$2.66 Billion | ▲ +33.9% |
| 2017 | 0.32x | NT$1.09 Billion | NT$996.52 Million | NT$3.40 Billion | — |